PodcastRx with Chris Bender - January 2025

For the first #PodcastRx episode of 2025, Chris - in the spirit of New Year's resolutions- explores some common sense but effective tenants for improved clinical decision making.

‍

Ahead of that, he details a few noteworthy expanded drug approvals (Vtama, Nemluvio, Zepbound) and revised treament guidelines (diabetes, metformin, borderline personaility disorder). And to close things out, he looks back at the ancient origins of the pharmacy profession.

‍

Listen here, or on your favorite podcast app! And please rate and/or review the show.

‍

References to Discussion Material:

‍

Into the Clinic:

FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

FDA Approves New IL-31 Drug for Eczema

FDA Approves First Medication for Obstructive Sleep Apnea

Standards of Care in Diabetes-2025

Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder, Second Edition

‍

Main Segment:

Choosing Wisely Recommendations

‍

Trivia Capsule:

Ebers Papyrus

The Canon of Medicine

The Islamic Roots of Modern Pharmacy

Pharmacopoeia Londinensis of 1618

Pharmacopoeia

The history of pharmacy

‍

‍

‍

‍

‍

‍